State Street Corp Merus N.V. Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

A detailed history of State Street Corp transactions in Merus N.V. stock. As of the latest transaction made, State Street Corp holds 244,676 shares of MRUS stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,676
Previous 235,688 3.81%
Holding current value
$13.1 Million
Previous $6.48 Million 69.99%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$28.03 - $51.82 $251,933 - $465,758
8,988 Added 3.81%
244,676 $11 Million
Q4 2023

Feb 14, 2024
BUY
$20.06 - $28.66 $319,154 - $455,980
15,910 Added 7.24%
235,688 $6.48 Million
Q3 2023

Nov 14, 2023
BUY
$20.13 - $27.29 $269,923 - $365,931
13,409 Added 6.5%
219,778 $5.18 Million
Q2 2023

Aug 14, 2023
SELL
$18.33 - $27.18 $1.52 Million - $2.25 Million
-82,692 Reduced 28.61%
206,369 $5.43 Million
Q1 2023

May 15, 2023
BUY
$14.25 - $20.5 $112,945 - $162,483
7,926 Added 2.82%
289,061 $5.32 Million
Q4 2022

Feb 14, 2023
BUY
$12.8 - $23.66 $1.17 Million - $2.16 Million
91,228 Added 48.04%
281,135 $4.35 Million
Q3 2022

Nov 15, 2022
BUY
$18.64 - $28.93 $94,467 - $146,617
5,068 Added 2.74%
189,907 $3.8 Million
Q2 2022

Aug 15, 2022
BUY
$13.98 - $29.25 $123,135 - $257,634
8,808 Added 5.0%
184,839 $4.19 Million
Q1 2022

May 16, 2022
BUY
$23.58 - $30.91 $331,275 - $434,254
14,049 Added 8.67%
176,031 $4.65 Million
Q4 2021

Feb 14, 2022
BUY
$20.0 - $32.29 $920,980 - $1.49 Million
46,049 Added 39.72%
161,982 $5.15 Million
Q3 2021

Nov 15, 2021
BUY
$16.48 - $27.23 $90,079 - $148,839
5,466 Added 4.95%
115,933 $2.55 Million
Q2 2021

Aug 16, 2021
BUY
$20.0 - $25.48 $1.47 Million - $1.87 Million
73,495 Added 198.79%
110,467 $2.33 Million
Q1 2021

May 17, 2021
BUY
$16.14 - $29.11 $174,876 - $315,406
10,835 Added 41.45%
36,972 $772,000
Q4 2020

Feb 16, 2021
SELL
$11.4 - $18.36 $1,493 - $2,405
-131 Reduced 0.5%
26,137 $458,000
Q3 2020

Nov 10, 2020
BUY
$10.57 - $16.0 $135,190 - $204,640
12,790 Added 94.9%
26,268 $315,000
Q2 2020

Aug 14, 2020
BUY
$10.5 - $17.36 $141,519 - $233,978
13,478 New
13,478 $217,000

Others Institutions Holding MRUS

# of Institutions
164
Shares Held
47.9M
Call Options Held
123K
Put Options Held
293K
View Full List

About Merus N.V.

MRUS Quotes by TradingView
  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.45B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email